Nautilus Biotechnology, Inc.

NASDAQ:NAUT

1.76 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Revenue 0008.21200000000000000000000
Cost of Revenue 1.6121.5971.5911.591.5151.421.1710.92100.8290.8060.2630.2770.30000000000
Gross Profit -1.612-1.597-1.5916.622-1.515-1.42-1.171-0.9210-0.829-0.806-0.263-0.277-0.30000000000
Gross Profit Ratio 0000.80600000000000000000000
Reseach & Development Expenses 12.28811.92412.41412.46611.99611.91210.8779.5879.5718.8569.6589.8938.2446.384.8353.8943.3172.7512.4700000
General & Administrative Expenses 6.8128.3538.6777.5357.0797.1047.1836.7176.2496.6166.3646.9236.3244.3173.5821.4260.710.6494.1270.3550.1780.0880.154111.684
Selling & Marketing Expenses 0-1.0857.593000000000000000000000
SG&A 6.8127.2687.6027.5357.0797.1047.1836.7176.2496.6166.3646.9236.3244.3173.5821.4260.710.6494.1270.3550.1780.0880.154111.684
Other Expenses 0-0.0190-0.0563.197-0.0143.0950.008-0.1320.7830.2590.1270.064-0.0160.008-0.0320.0490.045000000
Operating Expenses 19.119.19220.01620.00119.07519.01618.0616.30415.8215.47216.02216.81614.56810.6978.4175.324.0273.44.1270.3550.1780.0880.154111.684
Operating Income -19.1-20.789-21.607-17.024-15.878-15.808-18.06-17.225-15.82-15.472-16.022-16.689-14.568-10.697-8.417-5.32-4.027-3.4-4.127-0.355-0.178-0.088-0.154-111.684
Operating Income Ratio 000-2.07300000000000000000000
Total Other Income Expenses Net 2.6542.7792.8772.9773.1973.2083.0952.8951.7570.7830.2590.1270.064-0.0160.008-0.0320.0490.045-0.2730.7410.7950.9450.872738.284
Income Before Tax -16.446-18.01-18.73-17.024-15.878-15.808-14.965-13.409-14.063-14.689-15.763-16.689-14.504-10.713-8.409-5.352-3.978-3.355-3.270.3850.6170.8570.719626.6
Income Before Tax Ratio 000-2.07300000000000000000000
Income Tax Expense 001.548-3.0333.197-3.222-3.0952.886-1.889-0.783-0.2590.606-0.7340.312000-0.1690.6990.6940.750.9040.8320
Net Income -16.446-18.01-18.73-17.024-15.878-15.808-11.87-16.295-14.063-13.906-15.504-16.689-14.504-10.713-8.409-5.352-3.978-3.355-3.270.3850.6170.8570.719626.6
Net Income Ratio 000-2.07300000000000000000000
EPS -0.13-0.14-0.15-0.14-0.13-0.13-0.095-0.13-0.11-0.11-0.12-0.13-0.12-0.086-0.068-0.17-0.13-0.12-0.450.0540.0860.120.187.18
EPS Diluted -0.13-0.14-0.15-0.14-0.13-0.13-0.095-0.13-0.11-0.11-0.12-0.13-0.12-0.086-0.068-0.17-0.13-0.12-0.450.0540.0860.120.187.18
EBITDA -18.585-20.277-21.091-19.446-18.607-18.575-17.675-15.958-15.511-13.86-14.957-16.553-14.291-10.413-8.203-5.126-3.838-3.231-2.8390.3850.6170.8570.719626.6
EBITDA Ratio 000-2.24200000000000000000000